SLS (SELLAS Life Sciences Group) Tariff Resilience Score: 7/10 (As of Jun. 26, 2026)


SLS SELLAS Life Sciences Group Inc SLS
25 GF Score
Price $10.53
! 1 Warning Sign
View Full Analysis

What is SELLAS Life Sciences Group Tariff Resilience Score?

SELLAS Life Sciences Group SLS -0.09% 25 Tariff Resilience Score is 7 as of Jun. 26, 2026. GuruFocus rates SLS with a GF Score™ of 25/100. The stock has 1 warning sign investors should review. Among 1,378 Biotechnology companies, SELLAS Life Sciences Group ranks better than 90.42% on this metric.

SELLAS Life Sciences Group has the Tariff Resilience Score of 7, which implies that the company might have Highly Resilient.

SELLAS Life Sciences Group has Primarily operates in the biotech sector with limited exposure to tariffs. Global supply chain is minimal, and sales are mostly domestic. Historical tariff changes have had negligible impact. Mitigation strategies include strong pricing power and alternative suppliers.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes SELLAS Life Sciences Group might have Highly Resilient.

SELLAS Life Sciences Group  (NAS:SLS) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

SELLAS Life Sciences Group Tariff Resilience Score Related Terms

SLS vs SNDX, CAPR, AGIO: Tariff Resilience Score Comparison

For the Biotechnology subindustry, SELLAS Life Sciences Group's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SELLAS Life Sciences Group Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SELLAS Life Sciences Group's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where SELLAS Life Sciences Group's Tariff Resilience Score falls into.


SLS
25GF Score
SELLAS Life Sciences Group Inc SLS
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 7 mean?
SELLAS Life Sciences Group (SLS) has a Tariff Resilience Score of 7 as of Jun. 26, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, SELLAS Life Sciences Group ranks #132 out of 1378 companies in the Biotechnology industry, placing it in the top 9.6%.
Is SELLAS Life Sciences Group's Tariff Resilience Score too high?
SELLAS Life Sciences Group's current Tariff Resilience Score is 7. The Biotechnology industry median Tariff Resilience Score is 4.00. SELLAS Life Sciences Group's value of 7 is 75% above this industry median. Based on the distribution chart, SELLAS Life Sciences Group ranks #132 out of 1378 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, SELLAS Life Sciences Group has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does SELLAS Life Sciences Group's Tariff Resilience Score compare to SNDX and CAPR?
According to the Biotechnology industry distribution chart, SELLAS Life Sciences Group ranks #132 out of 1378 companies for Tariff Resilience Score. This places SELLAS Life Sciences Group in the top 10% of its industry — outperforming the majority of peers. The industry median Tariff Resilience Score is 4.00. SELLAS Life Sciences Group's value of 7 is 75% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,378 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SELLAS Life Sciences Group's current Tariff Resilience Score of 7 is 75% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SELLAS Life Sciences Group's current Tariff Resilience Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SELLAS Life Sciences Group stock overvalued right now?
SELLAS Life Sciences Group (SLS) has a current Tariff Resilience Score of 7. The current Tariff Resilience Score is 7 and 75% above the Biotechnology industry median of 4.00. SELLAS Life Sciences Group's overall GF Score™ is 25/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For SELLAS Life Sciences Group (SLS), the current Tariff Resilience Score is 7 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SELLAS Life Sciences Group Business Description

Other Exchanges RXK3:Germany
Address 7 Times Square, Suite 2503, New York, NY, USA, 10036
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
25GF Score

Get the complete analysis for SLS

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.53
Price